This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Anderson G, Donnellv S, Bradv T, Mintz PD, Sinor L, Daniels GL. An antibody to a high-frequency antigen found on red-cells, platelets, lymphocytes, and monocytes. Transfusion 1993;33:S23.AndersonGDonnellvSBradvTMintzPDSinorLDanielsGL.An antibody to a high-frequency antigen found on red-cells, platelets, lymphocytes, and monocytes.Transfusion1993;33:S23.Search in Google Scholar
Montgomery WM Jr, Nance SJ, Donnelly SF, et al. MAM: a “new” high-incidence antigen found on multiple cell lines. Transfusion 2000;40:1132–9. doi:10.1046/j.1537-2995.2000. 40091132.xMontgomeryWMJrNanceSJDonnellySFMAM: a “new” high-incidence antigen found on multiple cell lines.Transfusion2000;40:1132–9. doi:10.1046/j.1537-2995.2000.40091132.x10.1046/j.1537-2995.2000.40091132.x10988318Search in Google Scholar
Clayton A. Case study of an antenatal patient with an extremely rare antibody to a high-incidence antigen (anti-MAM). HAA Abstracts 2015;P175.ClaytonA.Case study of an antenatal patient with an extremely rare antibody to a high-incidence antigen (anti-MAM).HAA Abstracts2015;P175.Search in Google Scholar
Burgos A, Martinez V, Velliquette RW, et al. First report of anti-MAM in pregnancy without evidence of clinical HDFN or thrombocytopenia. Transfusion 2012;52(Suppl):26A.BurgosAMartinezVVelliquetteRWFirst report of anti-MAM in pregnancy without evidence of clinical HDFN or thrombocytopenia.Transfusion2012;52(Suppl):26A.Search in Google Scholar
Thornton N, Karamatic Crew V, Tilley L, et al. Disruption of the tumour-associated EMP3 enhances erythroid proliferation and causes the MAM-negative phenotype. Nat Commun 2020;11:3569. doi:10.1038/s41467-020-17060-4ThorntonNKaramatic CrewVTilleyLDisruption of the tumour-associated EMP3 enhances erythroid proliferation and causes the MAM-negative phenotype.Nat Commun2020;11:3569. doi:10.1038/s41467-020-17060-410.1038/s41467-020-17060-4736690932678083Search in Google Scholar
Li W, Fernandes BJ, Denomme GA. MAM is an N-glycan linked carbohydrate antigen expressed on all blood cells. Transfusion 2002;40:10S.LiWFernandesBJDenommeGA.MAM is an N-glycan linked carbohydrate antigen expressed on all blood cells.Transfusion2002;40:10S.Search in Google Scholar
Baglow L, Tilley L, Karamatic Crew V, et al. A novel EMP3 null allele detected in a patient with the MAM-phenotype. Vox Sang 2021;116(Suppl 1):32–3.BaglowLTilleyLKaramatic CrewVA novel EMP3 null allele detected in a patient with the MAM-phenotype.Vox Sang2021;116(Suppl 1):32–3.Search in Google Scholar
Liehr T, Kuhlenbäumer G, Wulf P, et al. Regional localization of the human epithelial membrane protein genes 1, 2, and 3 (EMP1, EMP2, EMP3) to 12p12.3, 16p13.2, and 19q13.3. Genomics 1999;58:106–8. doi:10.1006/geno.1999.5803LiehrTKuhlenbäumerGWulfPRegional localization of the human epithelial membrane protein genes 1, 2, and 3 (EMP1, EMP2, EMP3) to 12p12.3, 16p13.2, and 19q13.3.Genomics1999;58:106–8. doi:10.1006/geno.1999.580310.1006/geno.1999.580310331954Search in Google Scholar
Taylor V, Suter U. Epithelial membrane protein-2 and epithelial membrane protein-3: two novel members of the peripheral myelin protein 22 gene family. Gene 1996;175:115–20. doi:10.1016/0378-1119(96)00134-5TaylorVSuterU.Epithelial membrane protein-2 and epithelial membrane protein-3: two novel members of the peripheral myelin protein 22 gene family.Gene1996;175:115–20. doi:10.1016/0378-1119(96)00134-510.1016/0378-1119(96)00134-58917086Search in Google Scholar
Alaminos M, Dávalos V, Ropero S, et al. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Cancer Res 2005;65:2565–71. doi:10.1158/0008-5472.can-04-4283AlaminosMDávalosVRoperoSEMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.Cancer Res2005;65:2565–71. doi:10.1158/0008-5472.can-04-428310.1158/0008-5472.CAN-04-428315805250Search in Google Scholar
Kunitz A, Wolter M, van den Boom J, et al. DNA hyper-methylation and aberrant expression of the EMP3 gene at 19q13.3 in human gliomas. Brain Pathol 2007;17:363–70. doi:10.1111/j.1750-3639.2007.00083.xKunitzAWolterMvan den BoomJDNA hyper-methylation and aberrant expression of the EMP3 gene at 19q13.3 in human gliomas.Brain Pathol2007;17:363–70. doi:10.1111/j.1750-3639.2007.00083.x10.1111/j.1750-3639.2007.00083.x809553117610521Search in Google Scholar
Lv Q, Xiao W, Xiong Z, et al. Identification of candidate biomarker EMP3 and its prognostic potential in clear cell renal cell carcinoma. Front Biosci 2021;26:1176–90. doi:10.52586/5018LvQXiaoWXiongZIdentification of candidate biomarker EMP3 and its prognostic potential in clear cell renal cell carcinoma.Front Biosci2021;26:1176–90. doi:10.52586/501810.52586/501834856762Search in Google Scholar
Hsieh YH, Hsieh SC, Lee CH, et al. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway. Oncotarget 2015;6:34859–74. doi:10.18632/oncotarget.5414HsiehYHHsiehSCLeeCHTargeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.Oncotarget2015;6:34859–74. doi:10.18632/oncotarget.541410.18632/oncotarget.5414474149526472188Search in Google Scholar
Guo Q, Jing FJ, Xu W, et al. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/ AKT/NF-κB axis. Aging 2019;12:80–105. doi:10.18632/aging. 102598GuoQJingFJXuWUbenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/ AKT/NF-κB axis.Aging2019;12:80–105. doi:10.18632/aging.10259810.18632/aging.102598697768431895687Search in Google Scholar
Han M, Xu W. EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells. Tumour Biol 2017;39:1010428317718404. doi:10.1177/1010428317718404HanMXuW.EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells.Tumour Biol2017;39:1010428317718404. doi:10.1177/101042831771840410.1177/101042831771840428718375Search in Google Scholar
Wang YW, Li WM, Wu WJ, et al. Potential significance of EMP3 in patients with upper urinary tract urothelial carcinoma: crosstalk with ErbB2-PI3K-Akt pathway. J Urol 2014;192:242–51. doi:10.1016/j.juro.2013.12.001WangYWLiWMWuWJPotential significance of EMP3 in patients with upper urinary tract urothelial carcinoma: crosstalk with ErbB2-PI3K-Akt pathway.J Urol2014;192:242–51. doi:10.1016/j.juro.2013.12.00110.1016/j.juro.2013.12.00124333112Search in Google Scholar
Zhou W, Jiang Z, Li X, et al. EMP3 overexpression in primary breast carcinomas is not associated with epigenetic aberrations. J Korean Med Sci 2009;24:97–103. doi:10.3346/ jkms.2009.24.1.97ZhouWJiangZLiXEMP3 overexpression in primary breast carcinomas is not associated with epigenetic aberrations.J Korean Med Sci2009;24:97–103. doi:10.3346/jkms.2009.24.1.9710.3346/jkms.2009.24.1.97265097219270820Search in Google Scholar
Hong XC, Fen YJ, Yan GC, et al. Epithelial membrane protein 3 functions as an oncogene and is regulated by microRNA-765 in primary breast carcinoma. Mol Med Rep 2015;12:6445–50. doi:10.3892/mmr.2015.4326HongXCFenYJYanGCEpithelial membrane protein 3 functions as an oncogene and is regulated by microRNA-765 in primary breast carcinoma.Mol Med Rep2015;12:6445–50. doi:10.3892/mmr.2015.432610.3892/mmr.2015.4326462615126398721Search in Google Scholar
Evtimova V, Zeillinger R, Weidle UH. Identification of genes associated with the invasive status of human mammary carcinoma cell lines by transcriptional profiling. Tumour Biol 2003;24:189–98. doi:10.1159/000074429EvtimovaVZeillingerRWeidleUH.Identification of genes associated with the invasive status of human mammary carcinoma cell lines by transcriptional profiling.Tumour Biol2003;24:189–98. doi:10.1159/00007442910.1159/00007442914654713Search in Google Scholar
Mackay A, Jones C, Dexter T, et al. cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells. Oncogene 2003;22:2680–8. doi:10.1038/sj.onc.1206349MackayAJonesCDexterTcDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells.Oncogene2003;22:2680–8. doi:10.1038/sj.onc.120634910.1038/sj.onc.120634912730682Search in Google Scholar
Fumoto S, Hiyama K, Tanimoto K, et al. EMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma. Cancer Lett 2009;274:25–32. doi:10.1016/j.canlet.2008.08.021FumotoSHiyamaKTanimotoKEMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma.Cancer Lett2009;274:25–32. doi:10.1016/j.canlet.2008.08.02110.1016/j.canlet.2008.08.02118823699Search in Google Scholar
Xue Q, Zhou Y, Wan C, et al. Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer. Exp Mol Pathol 2013;95:313–8. doi:10.1016/j.yexmp.2013.07.001XueQZhouYWanCEpithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.Exp Mol Pathol2013;95:313–8. doi:10.1016/j.yexmp.2013.07.00110.1016/j.yexmp.2013.07.00123920144Search in Google Scholar
Zheng Z, Luan X, Zha J, et al. TNF-alpha inhibits the migration of oral squamous cancer cells mediated by miR-765-EMP3-p66Shc axis. Cell Signal 2017;34:102–9. doi:10.1016/j. cellsig.2017.03.009ZhengZLuanXZhaJTNF-alpha inhibits the migration of oral squamous cancer cells mediated by miR-765-EMP3-p66Shc axis.Cell Signal2017;34:102–9. doi:10.1016/j.cellsig.2017.03.00910.1016/j.cellsig.2017.03.00928336231Search in Google Scholar
Ma Q, Zhang Y, Liang H, et al. EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway. Cancer Lett 2018;430:97–108. doi:10.1016/j.canlet.2018.05.022MaQZhangYLiangHEMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway.Cancer Lett2018;430:97–108. doi:10.1016/j.canlet.2018.05.02210.1016/j.canlet.2018.05.02229778567Search in Google Scholar
Liu A, Zhang D, Yang X, Song Y. Estrogen receptor alpha activates MAPK signaling pathway to promote the development of endometrial cancer. J Cell Biochem 2019;120:17593–601. doi:10.1002/jcb.29027LiuAZhangDYangXSongY.Estrogen receptor alpha activates MAPK signaling pathway to promote the development of endometrial cancer.J Cell Biochem2019;120:17593–601. doi:10.1002/jcb.2902710.1002/jcb.2902731140648Search in Google Scholar
Jiang L, Li XP, Dai YT, et al. Multidimensional study of the heterogeneity of leukemia cells in t(8;21) acute myelogenous leukemia identifies the subtype with poor outcome. Proc Natl Acad Sci U S A 2020;117:20117–26. doi:10.1073/pnas. 2003900117JiangLLiXPDaiYTMultidimensional study of the heterogeneity of leukemia cells in t(8;21) acute myelogenous leukemia identifies the subtype with poor outcome.Proc Natl Acad Sci U S A2020;117:20117–26. doi:10.1073/pnas.200390011710.1073/pnas.2003900117744390832747558Search in Google Scholar
Kim EK, Koo JS. Expression of epithelial membrane protein (EMP) 1, EMP 2, and EMP 3 in thyroid cancer. Histol Histopathol 2022;37:51–61. doi:10.14670/HH-18-378KimEKKooJS.Expression of epithelial membrane protein (EMP) 1, EMP 2, and EMP 3 in thyroid cancer.Histol Histopathol2022;37:51–61. doi:10.14670/HH-18-378Search in Google Scholar
Mellai M, Piazzi A, Caldera V, et al. Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas. BioMed Res Int 2013;2013:756302. doi:10.1155/2013/756302MellaiMPiazziACalderaVPromoter hypermethylation of the EMP3 gene in a series of 229 human gliomas.BioMed Res Int2013;2013:756302. doi:10.1155/2013/75630210.1155/2013/756302377637024083241Search in Google Scholar
Pasini A, Iorio P, Bianchi E, et al. LOH 19q indicates shorter disease progression-free interval in low-grade oligodendrogliomas with EMP3 methylation. Oncol Rep 2012;28:2271–7. doi:10.3892/or.2012.2047PasiniAIorioPBianchiELOH 19q indicates shorter disease progression-free interval in low-grade oligodendrogliomas with EMP3 methylation.Oncol Rep2012;28:2271–7. doi:10.3892/or.2012.204710.3892/or.2012.204722992787Search in Google Scholar
Yue H, Xu Q, Xie S. High EMP3 expression might independently predict poor overall survival in glioblastoma and its expression is related to DNA methylation. Medicine 2018;97:e9538. doi:10.1097/md.0000000000009538YueHXuQXieS.High EMP3 expression might independently predict poor overall survival in glioblastoma and its expression is related to DNA methylation.Medicine2018;97:e9538. doi:10.1097/md.000000000000953810.1097/MD.0000000000009538594311929505529Search in Google Scholar
Guo XX, Su J, He XF. A 4-gene panel predicting the survival of patients with glioblastoma. J Cell Biochem 2019;120:16037–43. doi:10.1002/jcb.28883GuoXXSuJHeXF.A 4-gene panel predicting the survival of patients with glioblastoma.J Cell Biochem2019;120:16037–43. doi:10.1002/jcb.2888310.1002/jcb.2888331081973Search in Google Scholar
Shu C, Wang Q, Yan X, Wang J. Whole-genome expression microarray combined with machine learning to identify prognostic biomarkers for high-grade glioma. J Mol Neurosci 2018;64:491–500. doi:10.1007/s12031-018-1049-7ShuCWangQYanXWangJ.Whole-genome expression microarray combined with machine learning to identify prognostic biomarkers for high-grade glioma.J Mol Neurosci2018;64:491–500. doi:10.1007/s12031-018-1049-710.1007/s12031-018-1049-729502292Search in Google Scholar
Jun F, Hong J, Liu Q, et al. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma. Oncotarget 2017;8:14343–58. doi:10.18632/ oncotarget.11102JunFHongJLiuQEpithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.Oncotarget2017;8:14343–58. doi:10.18632/oncotarget.1110210.18632/oncotarget.11102536241027527869Search in Google Scholar
Martija AA, Pusch S. The multifunctional role of EMP3 in the regulation of membrane receptors associated with IDH-wild-type glioblastoma. Int J Mol Sci 2021 May 17;22:5261. doi:10.3390/ijms22105261MartijaAAPuschS.The multifunctional role of EMP3 in the regulation of membrane receptors associated with IDH-wild-type glioblastoma.Int J Mol Sci2021;May17;22:5261. doi:10.3390/ijms2210526110.3390/ijms22105261815661234067658Search in Google Scholar
Huang RY, Kuay KT, Tan TZ, et al. Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120). Oncotarget 2015;6:22098–113. doi:10.18632/oncotarget.4300HuangRYKuayKTTanTZFunctional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120).Oncotarget2015;6:22098–113. doi:10.18632/oncotarget.430010.18632/oncotarget.4300467314926061747Search in Google Scholar
Kusumoto Y, Okuyama H, Shibata T, et al. Epithelial membrane protein 3 (Emp3) downregulates induction and function of cytotoxic T lymphocytes by macrophages via TNF-alpha production. Cell Immunol 2018;324:33–41. doi:10.1016/j. cellimm.2017.12.001KusumotoYOkuyamaHShibataTEpithelial membrane protein 3 (Emp3) downregulates induction and function of cytotoxic T lymphocytes by macrophages via TNF-alpha production.Cell Immunol2018;324:33–41. doi:10.1016/j.cellimm.2017.12.00110.1016/j.cellimm.2017.12.00129269102Search in Google Scholar
Kahm YJ, Kim RK, Jung U, Kim IG. Epithelial membrane protein 3 regulates lung cancer stem cells via the TGF-β signaling pathway. Int J Oncol. 2021;59:80. doi: 10.3892/ ijo.2021.5261.KahmYJKimRKJungUKimIG.Epithelial membrane protein 3 regulates lung cancer stem cells via the TGF-β signaling pathway.Int J Oncol.2021;59:80. doi:10.3892/ijo.2021.5261.10.3892/ijo.2021.526134476496Search in Google Scholar
Cha YJ, Koo JS. Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors. PLoS One 2020;15:e0238466. doi:10.1371/journal.pone.0238466ChaYJKooJS.Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.PLoS One2020;15:e0238466. doi:10.1371/journal.pone.023846610.1371/journal.pone.0238466745495032857809Search in Google Scholar
Christians A, Poisel E, Hartmann C, von Deimling A, Pusch S. Characterization of the epithelial membrane protein 3 interaction network reveals a potential functional link to mitogenic signal transduction regulation. Int J Cancer 2019;145:461–73. doi:10.1002/ijc.32107ChristiansAPoiselEHartmannCvon DeimlingAPuschS.Characterization of the epithelial membrane protein 3 interaction network reveals a potential functional link to mitogenic signal transduction regulation.Int J Cancer2019;145:461–73. doi:10.1002/ijc.3210710.1002/ijc.3210730614533Search in Google Scholar
Xu Q. The Indian blood group system. Immunohematology 2011;27:89–93.XuQ.The Indian blood group system.Immunohematology2011;27:89–93.10.21307/immunohematology-2019-180Search in Google Scholar
Chen C, Zhao S, Karnad A, Freeman JW. The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol 2018;11:64. doi:10.1186/s13045-018-0605-5ChenCZhaoSKarnadAFreemanJW.The biology and role of CD44 in cancer progression: therapeutic implications.J Hematol Oncol2018;11:64. doi:10.1186/s13045-018-0605-510.1186/s13045-018-0605-5594647029747682Search in Google Scholar
Pályi-Krekk Z, Barok M, Kovács T, et al. EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44. Cancer Lett 2008;263:231–42. doi:10.1016/j.canlet.2008.01.014Pályi-KrekkZBarokMKovácsTEGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44.Cancer Lett2008;263:231–42. doi:10.1016/j.canlet.2008.01.01410.1016/j.canlet.2008.01.01418276068Search in Google Scholar
Midgley AC, Rogers M, Hallett MB, et al. Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts. J Biol Chem 2013;288:14824–38. doi:10.1074/jbc.M113.451336MidgleyACRogersMHallettMBTransforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts.J Biol Chem2013;288:14824–38. doi:10.1074/jbc.M113.45133610.1074/jbc.M113.451336366350623589287Search in Google Scholar
